Document Detail

The status of antithymocyte globulin therapy for adult patients in Japan: retrospective analysis of a nationwide survey.
MedLine Citation:
PMID:  18224413     Owner:  NLM     Status:  MEDLINE    
We conducted a nationwide survey on antithymocyte globulin (ATG) therapy for adult patients in Japan. We mailed questionnaires to 454 hospitals with hematology divisions, of which 181 (40%) responded, and the records of 448 patients were collected. Patient characteristics, hematological responses, and adverse effects were evaluated in 421 patients with sufficient data. A total of 366 patients had idiopathic aplastic anemia (AA), 29 had other types of AA, and 25 had other diseases. The response rate (RR) at 6 months was 54% for all patients, and 53% for those with idiopathic AA. Ten patients (2%) died within 30 days, and 11 (3%) died between 31 and 100 days after ATG therapy. In 346 patients with moderate to very severe AA, who received their first ATG therapy, factors that influence the outcomes of ATG therapy were extracted. Among 11 pre-treatment and therapy-related variables, three were found to be correlated with a higher RR: shorter duration of AA, no history of specific therapy for AA, and the use of CsA. Most notably, the RR of patients treated within 3 months of diagnosis, those between 3 months and 2 years, and those later than 2 years were 68% (130/190), 48% (54/113), and 13% (5/38), respectively.
Mamiko Hattori; Teruhiko Terasawa; Keitaro Tsushita; Makoto Utsumi; Fumio Kawano; Hidehiko Saito; Masanori Shimoyama; Haruhiko Ohashi
Related Documents :
19623153 - Initiation of early empiric treatment based on clinical features and early obtainable c...
24239823 - Eggshell thinning of osprey (pandion haliaetus) breeding in sweden and its significance...
23852263 - Anaesthetic drugs and survival: a bayesian network meta-analysis of randomized trials i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2007-12-08
Journal Detail:
Title:  International journal of hematology     Volume:  87     ISSN:  0925-5710     ISO Abbreviation:  Int. J. Hematol.     Publication Date:  2008 Jan 
Date Detail:
Created Date:  2008-01-28     Completed Date:  2008-10-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111627     Medline TA:  Int J Hematol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  48-55     Citation Subset:  IM    
Clinical Research Center for Blood Diseases, National Hospital Organization Nagoya Medical Center, Naka-ku, Nagoya 460-0001, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anemia, Aplastic / therapy*
Antilymphocyte Serum / therapeutic use*
Cross-Sectional Studies
Data Collection
Immunosuppressive Agents / therapeutic use*
Middle Aged
Remission Induction
Retrospective Studies
Survival Analysis
Reg. No./Substance:
0/Antilymphocyte Serum; 0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gene profiling of growth factor independence 1B gene (Gfi-1B) in leukemic cells.
Next Document:  Dramatic remission of anemia after thymectomy in a patient of idiopathic myelofibrosis with thymoma.